Trial Profile
Clinical Trials Insight: 700007666
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Jun 2008
Price :
$35
*
At a glance
- Drugs EWA 401 (Primary)
- Indications Chronic limb-threatening ischemia; Peripheral ischaemia
- Focus Adverse reactions; Therapeutic Use
- 19 May 2008 Results reported in a Sangamo media release.
- 11 Nov 2005 New trial record.